Nuclear medicine has made significant strides in the field of oncology, particularly through the development of molecular probes and targeted radiopharmaceuticals. This progress has transformed cancer ...

Collaboration leverages OBT's proprietary OGAP®-Verify discovery platform and drug development capabilities in alignment with BMS’s expertise to ...

Drug development involves significant risk and expense. With average development costs topping $1 billion per approved medicine and stubbornly high failure rates, pharmaceutical leaders are ...

As of spring 2026, a cancer drug that has spent years in clinical development as a Wnt/beta-catenin pathway blocker has been ...

(a) Success rate, timeline, and cost (in billions) of traditional drug development versus RNA drug development, along with a description of the evolutionary progress of the latter. (b) The future ...

A new India-Sweden research collaboration at Indraprastha Institute of Information Technology, Delhi is using artificial intelligence to help scientists outpace deadly pneumonia germs.

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Bullfrog AI Holdings, Inc. BFRG shares are trading higher on continued strength Tuesday after the company announced a ...